Thomas Illmer, Markus Schaich, Gerhard Ehninger, Christian Thiede. Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias. Haematologica 2007;92(1):137-138; https://doi.org/10.3324/haematol.10489.